Transcription of Oncology Medication Clinical Coverage
{{id}} {{{paragraph}}}
Example: dental hygienist
Oncology Medication Clinical Coverage
Oncology Medication Clinical Coverage Page 1 of 5 UnitedHealthcare Commercial Medical Benefit Drug Policy Effective 03/01/2022 Proprietary Information of UnitedHealthcare. Copyright 2022 United HealthCare Services, Inc. UnitedHealthcare Commercial Medica l Benefit Drug Policy Oncology Medication Clinical Coverage Policy Number: 2022D0030Z Effective Date: March 1, 2022 Instructions for Use Table of Contents Page Coverage Rationale .. 1 Applicable Codes .. 3 3 Benefit Considerations .. 4 References .. 4 Policy History/Revision Information .. 5 Instructions for Use .. 5 Coverage Rationale See Benefit Considerations Description This policy provides parameters for Coverage of injectable Oncology medications (including, but not limited to octreotide acetate , leuprolide acetate , leucovorin and levoleucovorin), including therapeutic radiopharmaceuticals, covered under the medical benefit based upon the National Comprehensive Cancer Network (NCCN) Drugs & Biologics Compendium (NCCN Compendium ).
acetate, leuprolide acetate, leucovorin and levoleucovorin), including therapeutic radiopharmaceuticals, covered under the medical benefit based upon the National Comprehensive Cancer Network (NCCN) Drugs & Biologics Compendium® (NCCN Compendium®). The Compendium lists the appropriate drugs and biologics for specific …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: